Atherogenic Index of Plasma ( AIP ): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study
Endocrinology, Diabetes & Metabolism · 2024-11 · 7 (6)
DOI: 10.1002/edm2.70007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 05.11.2024. Verfasst von Sahar Karimpour Reyhan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Obesity, Overweight. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
This study aimed to evaluate the relationships of conventional and calculated lipid indices with obesity or overweight in patients with type 2 diabetes (T2D).
Methods
In this cross‐sectional study, all participants were categorised into three groups: normal weight (18 ≤ BMI < 25), overweight (25 ≤ BMI < 30) and obese (BMI ≥ 30). Conventional lipid indices, including triglyceride (TG), total cholesterol, LDL‐C and HDL‐C, were measured. Lipid indices, including the atherogenic index of plasma (AIP), non‐HDL‐C, TC/HDL‐C, LDL‐C/HDL‐C, non‐HLD‐C/HDL‐C (atherogenic index, AI) and lipoprotein combine index (LCI), were calculated. The associations of these lipid indices with obesity and overweight status were evaluated using univariate and multivariate multinomial logistic regression analyses.
Results
In this study, 2661 patients with T2D, including 651 patients with normal weight, 1144 with overweight, and 866 with obesity, were recruited. According to a multinomial logistic regression analysis after adjustment for multiple confounders, the odds ratio (OR) was greater for the AIP than for other conventional and calculated lipid indices in overweight and obese patients with T2D. The AIP had a significant relationship with overweight, with an OR of 4.79 (95% CI: 1.65–13.85), and it had a significant relationship with obesity, with an OR of 13.64 (95% CI: 3.96–47.04). According to the ROC curve, with a cut‐off value of 0.68, AIP could predict obesity with 82% sensitivity and 55% specificity (AUC = 0.770, 95% CI: 0.729–0.812, p < 0.001).
Conclusion
Compared with other conventional and calculated lipid markers, the AIP is most strongly associated with obesity and overweight in patients with T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Mechanical Engineering School, University of Tehran, Tehran, Iran.
ORCID-Profile: Sahar Karimpour Reyhan, Amirhossein Yadegar, Manouchehr Nakhjavani, Soghra Rabizadeh
Zitieren
APA
Karimpour Reyhan, S., Yadegar, A., Samimi, S., Nakhaei, P., Esteghamati, A., Nakhjavani, M., Karimpour Reihan, S., & Rabizadeh, S. (2024). Atherogenic Index of Plasma ( AIP ): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study. Endocrinology, Diabetes & Metabolism, 7(6). https://doi.org/10.1002/edm2.70007
Vancouver
Karimpour Reyhan S, Yadegar A, Samimi S, Nakhaei P, Esteghamati A, Nakhjavani M, et al. Atherogenic Index of Plasma ( AIP ): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study. Endocrinology, Diabetes & Metabolism. 2024;7(6). doi:10.1002/edm2.70007
BibTeX
@article{KarimpourReyhan2024,
author = {Karimpour Reyhan, Sahar and Yadegar, Amirhossein and Samimi, Sahar and Nakhaei, Pooria and Esteghamati, Alireza and Nakhjavani, Manouchehr and Karimpour Reihan, Soheil and Rabizadeh, Soghra},
title = {Atherogenic Index of Plasma ( AIP ): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross‐Sectional Study},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2024},
volume = {7},
number = {6},
doi = {10.1002/edm2.70007}
}
EUVIMED